Introduction to the departments of Jixi People's Hospital

Obstetrics and Gynecology was established in 1956. Since 1986, the comprehensive strength of the department has been strengthened year by year, and it has become a specialty integrating medical treatment, teaching, scientific research and preventive health care, focusing on the diagnosis and treatment of difficult and serious diseases in obstetrics and gynecology. It was rated as a standard baby-friendly hospital in 1995.

After years of construction and development, the department has formed a well-trained and skilled medical and health backbone team, which enjoys a high reputation both inside and outside the city. There are 26 medical staff, including 2 chief physicians and professors; There are 5 deputy chief physicians and associate professors. The specialty is complete and the treatment method is perfect. There are gynecology, obstetrics, gynecology clinic and prenatal publicity room. There are 40 beds in this department, including 16 beds for mother and baby, 7 beds for family ward and 1 bed for high-risk ward. Obstetrics provides a series of services centered on perinatal health care. Obstetric diagnosis and monitoring of high-risk pregnant women, fetuses and newborns, specializing in improving maternal and infant health, prenatal and postnatal care, and improving population quality, especially perinatal prevention and treatment, prevention and treatment of pregnancy-induced hypertension syndrome, breastfeeding, and neonatal touching.

Diagnosis and treatment of common gynecological diseases and endocrine diseases in obstetrics and gynecology. Ureteral anastomosis and orthopedic surgery were performed by microsurgery, gynecological diseases were diagnosed and treated by video laparoscopy, and ovarian cysts and ectopic pregnancy were treated by surgery. Preoperative electronic colposcopy screening for cervical cancer is a complete method of early diagnosis, early treatment, early operation and early chemotherapy. Family planning provides birth control advice and guidance for women of childbearing age, carries out painless induced abortion, and diagnoses and treats female infertility. Hysterosalpingography enjoys a high reputation in the province. Intra-fascial hysterectomy and interventional treatment of hysteromyoma have filled the gap in Jixi city, making the professional level of obstetrics and gynecology in the leading position in the city. Ultrasound-guided puncture and automatic injection of sclerosing agent in the treatment of pelvic cyst won the third prize of Heilongjiang Science and Technology Progress Award 1997. Intrafascial hysterectomy 1998 won the third prize of new technology application in Heilongjiang province; Super-selective uterine artery embolization for hysteromyoma won the first prize of Jixi science and technology in 2002; The clinical research of video laparoscopic surgery won the second prize of Jixi Science and Technology Progress Award 2001; Intrafascial hysterectomy won the second prize of Jixi Science and Technology Progress Award1998; The quantitative determination of fibrin in the third trimester of pregnancy won the third prize of Jixi Science and Technology Award1997; Amniotic fluid replacement and painless abortion won the third prize of new technology application in Jixi People's Hospital; Electronic colposcopy cervical cancer pre-screening and improved vaginal hysterectomy won the third prize of scientific and technological progress in Jixi People's Hospital. The Center for Cardiovascular Disease Prevention and Control is located in the headquarters and is responsible for the prevention and treatment of cardiovascular diseases in Jixi area. There are 45 open beds. There are 28 medical staff in the cardiovascular department. Among them, chief physician 1 person, 4 deputy chief physicians, 2 attending physicians and 3 residents.

Cardiovascular medicine has a great influence in Jixi area. Support the development of cardiovascular medicine. We have successively purchased esophageal cardiac pacing stimulator, large physiological recorder, noninvasive cardiac function tester, dynamic electrocardiogram recorder, cardiac late potential tester, dynamic blood pressure monitor, cardiac activity flat test system, electrocardiogram workstation, CCU ward cardiac monitoring workstation (heart monitoring system produced by Hewlett-Packard Company, USA), large angiography system and other equipment.

65438-0989 for electrophysiological examination of esophageal pacing and right cardiac catheterization. 1990 was used to treat acute myocardial infarction by intravenous thrombolysis, which greatly reduced the mortality of myocardial infarction and improved the prognosis of such patients. 199 1 year for noninvasive cardiac function measurement. From 65438 to 0992, selective coronary angiography, percutaneous balloon mitral valvuloplasty and percutaneous atrioventricular node ablation were carried out, reaching the advanced level in China. After purchasing a large-scale angiographic system in 2000, Jixi Heart Disease Interventional Diagnosis and Treatment Center was established, and new technologies for heart disease interventional diagnosis and treatment were widely developed, including percutaneous transluminal coronary angioplasty, coronary stent implantation, peripheral vascular balloon angioplasty, percutaneous intracardiac electrophysiological examination, percutaneous bypass radiofrequency ablation and artificial pacemaker implantation. 65438-0992 cooperated with Beijing Fuwai Cardiovascular Hospital to observe the effect of captopril on the prognosis of acute myocardial infarction. 200 1 cooperated with the sino-german institute of molecular cardiology in Beijing fuwai cardiovascular hospital to carry out molecular investigation of cardiomyopathy. In 2002, in cooperation with China Hypertension Union, the effects of low molecular weight heparin and polarized liquid on acute myocardial infarction were studied.

Cardiovascular medical staff have written a lot of papers. Since 1987, right cardiac catheterization, selective coronary angiography and balloon angioplasty, coronary stent implantation, radiofrequency ablation for supraventricular tachycardia, percutaneous balloon mitral valvuloplasty, permanent artificial pacemaker implantation and clinical application of intracardiac electrophysiological examination have successively won municipal and hospital scientific and technological progress awards. Published and exchanged dozens of papers in national and provincial magazines and academic seminars. Department of Respiratory Medicine was established 1989, with 24 beds, including 3 deputy chief physicians. It is the only specialized treatment department for respiratory diseases in Jixi City.

With strong technical force, the department can accurately diagnose and treat a variety of common diseases, frequently-occurring diseases such as tracheitis, emphysema, pulmonary heart disease, pneumonia, asthma, lung cancer, rare diseases, difficult diseases such as pulmonary embolism, pleural lesions and various internal diseases of respiratory system, especially ARDS (acute respiratory distress syndrome), which is advanced in China and has rich clinical experience in critical rescue of respiratory system.

The department took the lead in carrying out scientific research projects such as CT-guided interventional therapy for lung cancer, pulmonary embolism, fiberoptic bronchoscopy, percutaneous lung, chest and diaphragm biopsy, and carried out the diagnosis and treatment of pulmonary embolism and pulmonary interstitial fibrosis. And has a variety of advanced treatment equipment such as lung function tester and intensive care monitor.